CIK 0000910267
TTNP TITAN PHARMACEUTICALS INC
Insider trading from SEC Form 4. Last filing Oct 8, 2025.
In brief
TITAN PHARMACEUTICALS INC (TTNP) has 7 SEC Form 4 filings on file from 6 insiders, the latest filed on Oct 8, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at TITAN PHARMACEUTICALS INC, scored.
Transactions
Every row filed, 10 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Avraham Ben-Tzvi director | DDisposition to issuer Common Stock | -3,313 | - | - | 0 | Oct 8, 2025 |
| Oct 1, 2025 | Avraham Ben-Tzvi director | DDisposition to issuer Option to Purchase Common Stockderivative | -1,250 | - | - | 0 | Oct 8, 2025 |
| Oct 1, 2025 | Avraham Ben-Tzvi director | DDisposition to issuer Option to Purchase Common Stockderivative | -5,000 | - | - | 0 | Oct 8, 2025 |
| Mar 18, 2024 | Choon Hau Choong owner | CConversion Common Stock | +54,132 | $0.00 | $0 | 3,802,100 | Mar 27, 2024 |
| Mar 18, 2024 | Choon Hau Choong owner | CConversion Convertible Promissory Notederivative | - | $0.00 | - | 0 | Mar 27, 2024 |
| Oct 25, 2023 | Katherine Beebe President and COO | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
| Oct 25, 2023 | Avraham Ben-Tzvi director | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
| Oct 25, 2023 | Eric Howard Greenberg director | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
| Oct 25, 2023 | Matthew Charles McMurdo director | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
| Oct 25, 2023 | David Natan director | AGrant or award Common Stock | +16,250 | $0.00 | $0 | 66,250 | Oct 26, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Katherine BeebePresident and COO
- Avraham Ben-Tzvidirector
- Choon Hau Choongowner
- Eric Howard Greenbergdirector
- Matthew Charles McMurdodirector
- David Natandirector
Questions about TTNP
Answered from the filings on this page, as of the latest one.
Are insiders buying TTNP?
No. In the last 90 days no insider at TITAN PHARMACEUTICALS INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade TTNP on the open market?
No open-market trade has been scored at TITAN PHARMACEUTICALS INC. The latest Form 4 on file was filed on Oct 8, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at TITAN PHARMACEUTICALS INC?
6 people have filed a Form 4 at TITAN PHARMACEUTICALS INC, among them Katherine Beebe (President and COO), Avraham Ben-Tzvi (director), Choon Hau Choong (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.